All In Biotech

Drug Trial Radar · NCT07477990

Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device in Adult Patients With Moderate to Severe Generalized Anxiety Disorder

Phase III, Randomized, Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device With Conventional Drug Treatment, Compared to Conventional Drug Treatment Alone, in Adult Patients With Moderate to Severe Generalized Anxiety Disorder

Last checked: Nov 20, 2026Latest source record: Apr 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 162 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

162

Planned (sponsor's estimate)

Start

Mar 29, 2026

Primary completion

Jun 29, 2027

Study completion Jul 1, 2027

Sponsor

Lead sponsor
Psicofarma, S.A. De C.V.Industry
Sponsor type
Industry
First posted
Mar 17, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the superiority of cognitive behavioral therapy using the Aurora® digital medical device + conventional drug treatment, compared to conventional drug treatment alone, in reducing anxiety symptoms, as assessed by the change in the GAD-7 scale at 12 weeks of treatment, relative to baseline.

Conditions

  • General Anxiety Disorder

Interventions

  • App AURORA (Digital Therapy) + conventional treatmentOther

    81 patients using Digital Therapy Aurora + conventional pharmacological treatment for 12 weeks

  • Pharmacological conventional treatmentDrug

    81 patients using conventional pharmacological treatment for 12 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. GAD-7 scaleTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Servicios Especializados En Ensayos Clinicos, Seec, Sc

    Mexico City, Mexico City, Mexico · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.